 |
 Jim Weiss |
Healthcare marketing and communications network W2O Group today announced that it has rebranded under a new name, Real Chemistry.
The independent agency, in a statement, said the name change addresses the disruption facing the healthcare sector since the outbreak of the COVID-19 pandemic, an environment in which information and services are increasingly delivered via intelligent technologies and one where the patient wields more control than ever.
“Innovation in healthcare has never moved faster or been more important,” Real Chemistry founder and CEO Jim Weiss told O’Dwyer’s. “That is why this moment is about so much more than a new name or approach. It’s about how our ethos of action, our two decades of intentional evolution and our drive for constant improvement helped us create what we see as the real chemistry between people and the brands born to change their lives.”
The San Francisco-headquartered network, which was founded in 2001, is the number-one independent healthcare PR firm, according to O’Dwyer’s annual rankings, accounting for about $219 million in net fees in 2019.
Charlie Chapman, a policy advisor to Health & Human Services Secretary Robert Kennedy Jr., has joined BGR’s health & life sciences practice.
The future of DTC should foster understanding and trust, as well as improving clinical conversations.
Healing the Sick Care System: Why People Matter, a new book from FINN Partners chair global health and purpose Gil Bashe, says that the current healthcare system is not broken because it lacks innovation, talent or investment, but because it has lost sight of the people it exists to serve.
